A compound prescription is the common implemental fashion of traditional Chinese medicines (Kampo). Studies on compound prescriptions now are putting the emphasis on the standardization and modernization; pharmacokinetics is a difficult point the compound prescriptions. Many papers have studied the pharmacokinetic parameters of one component in a compound prescription to clarify the pharmacokinetic regular of the entire prescription. 1-3) This idea has obvious limitations. A few papers reported pharmacokinetic studies on several constituents in a compound prescription by HPLC or enzyme immunoassay (EIA) method, 4-6) but no direct evidence for the systemic pharmacokinetic studies on multiconstituents in a compound prescription has been presented.
and detection. The mass spectrometer was tandem on a 2790 Waters HPLC apparatus (Waters Co., U.S.A.), and data were analyzed by MassLynx 3.5 software.
Preparation of Huangqin-Tang and Single Herb Decoctions Huangqin-Tang and single herb decoctions were prepared using our method. 7) Before oral administration, the contents of the constituents in each decoction were detected by HPLC.
Animals and Treatments Male Wistar rats weighing 300-350 g were purchased from the Institute of Experimental Animals, Chinese Academy of Medical Sciences, and fasted overnight (16 to 18 h) prior to the experiments of oral administration of Huangqin-Tang decoction or the single herb decoction with a dose of 10 g · kg Ϫ1 , but water was allowed ad libitum. The animals were anesthetized with chloral hydrate for surgical procedures. At intervals of 0, 1, 2, 4, 8, 12, 24, 36 and 48 h after oral administration, the abdomen was exposed by a midline abdominal incision and the blood was collected from the portal vein inferior to the liver by a heparinized injector. Then the blood samples were centrifuged at 3000 rpm for 15 min to separate plasma, and then the plasma samples were stored at Ϫ20°C for later analysis.
Pretreatment Procedure of the Samples for HPLC Thawed plasma samples were treated with SPE cartridges, which had beforehand been activated with 3 ml methanol and equilibrated with 6 ml deionized water, respectively. Using a water pump and a suction flask, the solutions in the cartridge were removed. Then the plasma sample was added to the activated SPE cartridge, which was successively rinsed with 10 ml water. The compounds were eluted with 2-3 ml methanol, the elution was collected and evaporated under a stream of nitrogen at 35°C, and the dry residue was reconstituted with 100 ml methanol. Finally, the mixture was shaken well and was transferred to another HPLC test tube; the injection volume of the sample for HPLC was 20 ml.
Validation of HPLC Analytical Method 9-11) HPLC Conditions: The constituents and metabolites in the samples were simultaneously analyzed by our HPLC method with a few modifications 7) : A Wakosil II 5C18-AR reversed-phase column (particle size 5 mm, 4.6ϫ150 mm i.d., SGE Co., Australia) was used. The mobile phase was composed of A (MeOH-HAC 100 : 0.5, v/v)ϪB (Water-HAC 100 : 0.5, v/v) with gradient elution (0 min, 30 : 70; 15 min, 40 : 60; 30 min, 60 : 40; 40 min, 80 : 20; 50 min, 100 : 0). The flow-rate was 1 ml · min Ϫ1 . The operating temperature was maintained at 25°C.
Linearity: Each reference substance was accurately weighed and dissolved in methanol to 1 mg · ml Ϫ1 , respectively. The appropriate amount of each reference substance solution was mixed and diluted with methanol. The whole volume of standard solution mixture was 1 ml. Seven different volumes of standard solution mixture were pipetted to other tubes. After evaporation to dryness under a nitrogen stream, 1 ml of blank rat plasma was added to each tube to prepare seven concentrations of standard plasma samples. The treatment of the plasma was as described above. Linearity of the responses was determined for the seven concentrations by three injections for each level. The computer made the standard curve according to the peak area of each compound. The contents of these constituents in the test samples were calculated using the regression parameters obtained from the standard curve. The limit of quantitation of the method for each constituent was detected when the signal to noise ratio (S/N) equaled 5.
Accuracy: Three concentrations (high, medium and low) of standard solution mixture in the blank rat plasma were detected five times on the same day for intra-day and continuously for five days for the inter-day accuracy variation test.
Recovery: Two concentrations of standard solution mixture were evaporated to dryness. The rat plasma samples after oral administration of Huangqin-Tang with known amounts of the constituents, were added to the tubes with the dry residue, and the recovery rates of the added amounts were calculated.
Stability: Three concentrations of plasma samples, which had been prepared for HPLC analysis, were put aside at room temperature for 12 h, or stored in a refrigerator at 4°C for 1, 3 and 5 d. The average peak area of the constituents in the samples and relative standard deviation (RSD) were calculated.
LC/MS Qualitative Analysis for the New Metabolite-VD-I A new metabolite was found in the rat plasma samples after oral administration of Huangqin-Tang or the single herb Huangqin decoction. By contrasting the retention time (RT) with other reference substances in Radix Scutellariae, we initially speculated that this new metabolite was visidulin I-3,5,7,2Ј,6Ј-penta hydroxy flavone. Subsequently, LC/MS was utilized for further identification of the metabolite. Firstly, the reference substance of VD-I was analyzed by mass spectrometer with positive ion detection [MϩH ϩ ]. Voltage of the capillary source and cone was 3.20 kV and 40 V. The source temperature and desolvation temperature was 100 and 150°C, respectively. Cone gas flow and desolvation gas flow was 104 l/h and 611 l/h, respectively. m/z of the precursor ion was 301 (the chemical structure of VD-I is shown in Fig. 1 ), m/z of the characteristic fragment ion by produced one collision was 286. Secondly, the reference substance and rat plasma sample were analyzed by LC/MS, the selected reaction monitoring mode was m/z 301→286, and the mobile phase modified as MeOH-H 2 O-HAC (50 : 50 : 0.5, v/v), RT of VD-I under this condition was 11.6 min. The peak presence in the ion current chromatogram with the same RT from the different samples indicated that the compounds had the same collisional fragment under this MS mode.
Pharmacokinetic Analysis The concentration-time data were computer fitted using a program of Pharmacokinetics 3p97 edited by the Mathematics Pharmacological Committee, Chinese Pharmacological Society. The following pharmacokinetic parameters were calculated: peak concentration (C max ), time of maximum plasma concentration (T peak ), half-life (T 1/2 ), area under the concentration-time curve (AUC 0-lim ), volume of distribution (V d ), clearance (C l ), elimination rate constant (K e ) and other parameters. The resi- dence time (MRT) was calculated by the statistical moment method of non-compartmental pharmacokinetic analysis. Statistical Analysis Data were expressed as the mean and standard deviation (S.D.) for each group. The significance of differences was assessed by Student's t-test.
RESULTS
HPLC The regression equations, correlation coefficient (g) and linearity ranges of the constituents of Huangqin-Tang in the rat plasma sample are shown in Table 1 , the amount of standard substances OG and PM-I was not enough for calibration graphs, the contents were of a relative value. The limit of quantitation of BG, WG and PF was 20 ng · ml Ϫ1 , that of B, W, O, LG, GA and L was 10 ng · ml Ϫ1 , and GL was 40 ng · ml Ϫ1 . The results of intra-day and inter-day (nϭ5) variations of the constituents in rat plasma samples are shown in Tables 2 and 3 , the coefficient of variation (CV) did not exceed 10%, the accuracy rates were all within 80-120%. The recovery results of the constituents in plasma samples are shown in Table 4 , CV of recovery was less than 20% at low concentration, and less than 15% at medium and high concentrations; the recovery rates were all more than 80%. Results of the stability test showed that RSD were within 5% under all conditions, so the samples were stable during the test process. The accuracy, recovery and stability tests all met the requirements of the quantitative determination in biological samples. The HPLC chromatograms of the constituents and their metabolites of Huangqin-Tang in rat plasma samples are shown in Fig. 2 . LC/MS m/z of the precursor ion of pure VD-I is 301 by positive ion detection [MϩH ϩ ], and m/z of produced characteristic fragment ion by one collision was 286 (mass spectra of precursor ion and product ion are shown in Fig. 3 ). The peak of pure VD-I presented at 11.6 min in the ion current chromatogram with scan mode m/z 301→286. Under the same conditions, the rat plasma sample of Huangqin-Tang post-administered was analyzed by LC/MS; we found the peak appeared at the same time in the ion current chromatogram (ion current chromatograms of pure VD-I and rat plasma sample are shown in Fig. 4 ). The targeted compound in the rat plasma sample had the same m/z of precursor ion and produced fragment ion with pure VD-I; combined with the HPLC analysis, we could confirm that the new metabolite in the rat plasma of post-administration of Huangqin-Tang or single herb Huangqin decoction was VD-I (3,5,7,2Ј,6Ј-penta hydroxy flavone).
Pharmacokinetics The pharmacokinetic parameters of the constituents and metabolites after oral administration of Huangqin-Tang or single herb decoction at a dose of 10 g · kg Ϫ1 to rats, are shown in Table 5 . All concentration- time curves corresponded to the one-compartment model. The constituents of BG, WG, OG, VD-I and LG had higher C max and AUC 0-lim in the compound prescription than in the single herb decoction, among them WG had significant differences on half-life of absorption phase (T 1/2 (K a )), T (peak), C max and AUC 0-lim . The constituents of PF, W and O had only a higher AUC 0-lim in the compound prescription than in the single herb decoction, and O had a significant difference.
DISCUSSION
Despite the compound prescriptions having been used for over thousands years in China, the mechanism of the compound prescription was dim. Few reports have investigated the reciprocity to pharmacokinetics of the herbal drugs in a prescription. Meselhy et al. 5) had found that two formulas, Toki-Shakuyaku-San (TS) and Shakuyaku-Kanzo-To (SK), were significantly different on the disposition of PM-I. Bando et al. 6) had studied the pharmacokinetics of PF, PM-I, GL and GA in the SK, single herb Glycyrrhiza decoction (GR) and single herb Paeony decoction (PR). They concluded that the oral administration of PR, GR and SK differed in the pharmacokinetics of PF, PM-I and GA. In this paper, we believed that due to their mutual influence, the constituents in the compound prescription and in the single herb decoction had obvious differentiations on the pharmaco-kinetic parameters. Furthermore, there are different influences on the different links of the process in vivo. Following the general trends of C max and AUC, two very significant parameters of the most constituents in Huangqin-Tang which are increased in the compound prescription, T 1/2 (K a ) of BG decreased whereas that of WG increased in the compound prescription. This suggested that the compound prescription formality could improve the absorption of BG from gastrointestinal tract into the blood, and postpone the absorption of WG, and then that may prolong the metabolism process of WG in the gastrointestine; T 1/2 (K e ) of OG decreased whereas that of W increased in the compound prescription, suggesting that the compound prescription formality could improve the distribution of OG to the various tissues, and postpone the tissue distribution of W. In short, most constituents in the compound prescription had delayed absorption and elimination, a longer residence time in the body, and higher C max and AUC 0-lim , than they did in the single herb decoction. Therefore, the constituents in the compound prescription were more efficient and durable, making them more promising in exerting pharmacological effects in vivo.
The time courses of the constituents' plasma concentration after oral administration of Huangqin-Tang or single herb decoction to rats are shown in Fig. 5 . The constituents of WG and OG presented double-peaks of plasma concentration at 4 and 24 h, respectively, and persisted over 48 h. Thus we pre- sumed that other constituents may convert to WG and OG in the rat body; the second peak of plasma concentration after 8 h was the metabolite peak. By human intestinal bacteria in vitro, BG, WG and OG were converted to their aglycones B, W and O, respectively. There are manifold metabolites of BG in urine and bile sample, OG as its metabolite appeared in both samples, [12] [13] [14] but it was not reported that WG and OG as its metabolites were present in the plasma. The metabolism routes of WG and OG, as metabolites in rat plasma, are still not clear. We also found that the plasma concentration of BG was not higher than WG and OG in the compound prescription (AUC 0-lim of BG was 4044.98Ϯ2201.36, WG and OG were 41984.69Ϯ3369.82 and 13692.44Ϯ6352.11, respectively). As a mark substance in Radix Scutellariae, BG has often been selected to represent the entire compound prescription for pharmacokinetic study. However, it is not appropriate to use BG to identify the pharmacokinetic regular of the entire compound prescription, at least for Huangqin-Tang in this experiment. The content of BG in the prescription was rather large, and its aglycone B as the main metabolite with the largest concentration was present in the cecum contents of the animals, but the content of B in the rat plasma was very low, and could not be detected 4 h after oral administration. Maybe it could be accounted for its biotransformation to other compounds or its quick elimination in vivo. It was reported that BG mainly existed as an original compound form in the rat plasma, although it could be converted to B by intestinal bacteria and absorbed from the gut; B was restored to its original form by UDP-glucuronosyltransferase in intestinal mucosa. 15) Traditionally, thin-layer chromatograpy (TLC) and HPLC methods have been used for the characterization of herbal medicine. However, the sensitivity and specificity of these techniques presents an increasing technical challenge. As a newly developed analytical technique, LC/MS/MS combines high performance liquid chromatography with tandem mass 916 Vol. 26, No. 7 spectrometry. Due to its ability to detect co-eluting, closelyrelated substances based on unique precursor/product ion combinations, the technique can be used to determine the identity and the content of low levels of drugs and their metabolites in biological fluids with high specificity and sensitivity. Some constituents in traditional medical herbs and their derivations have been studied by the LC/MS technique. [16] [17] [18] In our study, it is a pity that the LC/MS instrument could collide only one time to obtain the product. The new metabolite was present in the plasma after oral administration of Huangqin-Tang or single herb Huangqin decoction, so we judged that the new metabolite was derived from Radix Scutellariae. HPLC comparison with other reference substances in this herb showed that compound VD-I had the same RT and UV spectra with the new metabolite. LC/MS analysis results indicated that the targeted compound in the rat plasma sample had the same m/z of precursor ion and produced fragment ion with pure VD-I; we then inferred that the new metabolite was VD-I. The metabolite needs to be isolated and collected from the plasma to characterize its structure in its further study. VD-I was extracted and isolated from the Radix Scutellariea before, but it could not be found in the water decoction. The concentration of VD-I in rat plasma was detected after quality identification; it had quite high plasma concentration within 48 h after oral administration (AUC 0-lim of VD-I was 6385.22Ϯ1465.32 and 4412.72Ϯ1450.32 in Huangqin-Tang and single herb decoction, respectively). No evidence of its derivation or pharmacological effects were reported; accordingly, it offers promise for further research. Another finding in the study was that the plasma concentration of GL and its metabolite GA were too low to detect. It had been said that bioavailability of GL was very low, 19) but we were not able to state that both GA and GL had a trace plasma concentration after oral administration of Huangqin-Tang and single herb Gancao decoction.
